- Fee assured
- Verified this account
- Female urology
- Impotency and infertility
- Urinary tract stones
- Urological malignancy
My aim has always been to offer the best of modern treatment allied to the best standards of traditional medical care with an emphasis on communication of complex issues to patients so they understand their choices.
I am a Reviewer for NHS Health Technology Assessment programme (2003-6 and 2006-15) and a Specialist Advisor to the NICE Interventional Procedures Programme (2003-15).
I am Chairman or Steering Committee member of 2 nationally funded research trials (UNBLOCS and MASTER).
Areas of interest
Urolift treatment pioneer; Ejaculatory sparing prostatic surgery: Prostate cancer; Robotic surgery; Stone disease; Andrology; Fertility, Infertility and assisted conception; Vasectomy reversal; Urinary tract disorders; Urinary infection; Prostate disease; Urinary symptoms; BPH / LUTS; treatment with preservation of sexual function;Blood in the urine or haematuria; Renal colic and stones; Second opinions; Medico-legal opinions; New therapies;
Anaesthetists worked with
I have been an innovator in benign and cancerous conditions of the prostate and in stone disease, pioneered laser surgery and have recently developed the Urolift treatment for men with urinary problems who wish to preserve sexual function.
NHS Silver Merit Award
Visiting Professor, University of Hertfordshire Faculty of Health and Human Sciences 2005 onwards.
Hunterian Professor of the Royal College of Surgeons of England.
Over !50 published scientific papers, 3 books and 23 Chapters in text books including Medical therapy of BPH in the urologists' "bible" Campbell - Walsh Urology, 1th ed. Philadelphia, USA:2016
A full list is available at: http://www.tommcnicholasurology.com/resources/CV-2013-Refs.pdf
Various media outlets, most recently the Daily Mail twice in 2012 and The Independent twice in 2014 about new treatments and the Urolift device.
Courses offered to GPs
Regular lecturer to trainee and GP meetings.
I use the International prostate symptom score (IPSS) and Quality of Life (QofL) system as part of diagnosis and both before and after every treatment to measure response. The IPSS/QofL is well validated for both male and female urinary symptoms and their response to treatment.
Reference number 2406921
Professional bodies (positions held - last 3 yrs)
- Past President, Section of Urology, for 2015 Royal Society of Medicine, London 2016
Affiliations / memberships
member of the American Urological Association and the European Association of Urology.
- Pinehill Hospital, SG4 9QZ
- 14:00 - 17:30
- 01462 422822
- Pinehill Hospital, SG4 9QZ
- 08:00 - 12:00
- 01462 427207
- Spire Harpenden Hospital, AL5 4BP
- 09:00 - 13:00
- 01582 763191
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.
In the event of an urgent query following treatment, Bupa members should use the following contact details
01462 422 822